These DCs induced insulin‐specific tolerance in effector/memory CD4+ T cells from T1DM patients, characterized by reduced T‐cell proliferation, decreased IL‐2 and IFN‐γ expression, and increased IL‐10 secretion. This evidence concerns the gene INS and type 1 diabetes mellitus.